Aflibercept for diabetic macular edema

被引：0
|
作者：
Udaondo, Patricia [1 ]
Garcia-Delpech, Salvador [1 ]
Matinez-Costa, Rafael [1 ]
Navarro-Piera, Juan [2 ]
Cisneros-Lanuza, Angel [1 ]
机构：
[1] La Fe Univ & Polytech Hosp, Valencia, Spain
[2] Francesc Borja Hosp, Gandia, Spain
来源：
EXPERT REVIEW OF OPHTHALMOLOGY | 2014年 / 9卷 / 04期
关键词：
aflibercept; anti-VEGF; avastin; intravitreal injection; laser; macula; macular degeneration; macular edema; anibizumab; retina;
D O I：
10.1586/17469899.2014.931809
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Different intravitreal anti-VEGF medications have been used for the management of retinal vascular disorders with highly satisfactory results and good safety profiles. Aflibercept, a new anti-VEGF drug with a different mechanism of action compared with prior therapies, has recently emerged. The results of aflibercept Phase II and III studies show its efficacy for the treatment of wet age-related macular degeneration, macular edema secondary to central retinal vein occlusion and diabetic macular edema.
引用
收藏
页码：263 / 268
页数：6
相关论文
共 50 条
  • [31] Pretreatment factors in managing protocol with aflibercept in patients with diabetic macular edema
    Tanaka, Saori
    Miyamoto, Noriko
    Kusuhara, Sentaro
    Iwami, Hisashi
    Yamamoto, Shogo
    Yoshitake, Shin
    Hirota, Yuji
    Nakamura, Makoto
    Ikeda, Masahiro
    Gomi, Fumi
    Kurimoto, Yasuo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [32] Treatment of Diabetic Macular Edema with Aflibercept and Micropulse Laser (DAM Study)
    Koushan, Keyvan
    Eshtiaghi, Arshia
    Fung, Pauline
    Berger, Alan R.
    Chow, David R.
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 1109 - 1115
  • [33] Use of ziv-aflibercept in diabetic macular edema in a Ghanaian population
    Imoro Zeba Braimah
    Winfried M. Amoaku
    Eye, 2022, 36 : 40 - 44
  • [34] Aflibercept Monotherapy versus Bevacizumab-First for Diabetic Macular Edema
    Patel, Nimesh A.
    Al-Khersan, Hasenin
    Yannuzzi, Nicolas A.
    Lin, James
    Smiddy, William E.
    OPHTHALMOLOGY RETINA, 2023, 7 (05): : 413 - 419
  • [35] Comparative Effectiveness Trial of Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
    Sun, Jennifer K.
    DIABETES, 2015, 64 : A76 - A77
  • [36] Therapeutic effect of simultaneous intravitreal dexamethasone and aflibercept on diabetic macular edema
    Tai-Chi Lin
    Yu-Chien Chung
    Tsui-Kang Hsu
    Hsin-Wei Huang
    Yi-Ming Huang
    Yi-Chang Chou
    Chen-Yu Chao
    Po-Chen Tseng
    Acta Diabetologica, 2022, 59 : 501 - 508
  • [37] Efficacy and safety of aflibercept in diabetic macular edema: real life study
    Hrarat, Linda
    Auregan, Audrey Giocanti
    Buffet, Sylvia
    Fajnkuchen, Franck
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [38] Comparison of efficacy of intravitreal ranibizumab and aflibercept in eyes with diabetic macular edema
    Oshitari, T.
    Shimizu, N.
    Tatsumi, T.
    Takatsuna, Y.
    Arai, M.
    Sato, E.
    Yamamoto, S.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [39] Use of ziv-aflibercept in diabetic macular edema in a Ghanaian population
    Braimah, Imoro Zeba
    Amoaku, Winfried M.
    EYE, 2022, 36 (SUPPL 1) : 40 - 44
  • [40] Aflibercept versus ranibizumab for diabetic macular edema: A meta-analysis
    Chen, Haiyan
    Shi, Xuehui
    Zhang, Wang
    Han, Qianqian
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024, 34 (03) : 615 - 623
12345